NASDAQ : LUCY
Lucyd, Inc — Key statistics
Healthcare · Medical Instruments & Supplies · United States
Last price 0.8307 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 7.24M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Key statistics
Valuation
| Measure | Value |
|---|
| Market Cap | 7.24M |
| Enterprise Value | 3.49M |
Dates
| Measure | Value |
|---|
| Earnings Date | Nov 12, 2026 |
| Ex-Dividend Date | n/a |
Shares
| Measure | Value |
|---|
| Current Share Class | 8.71M |
| Shares Outstanding | 8.71M |
| Shares Change (YoY) | +132.62% |
| Shares Change (QoQ) | +2.55% |
| Owned by Insiders (%) | 6.87% |
| Owned by Institutions (%) | 13.24% |
| Float | 8.11M |
Ratios
| Measure | Value |
|---|
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 2.12 |
| Forward PS | 1.32 |
| PB Ratio | 0.77 |
| P/TBV Ratio | 1.15 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Evratios
| Measure | Value |
|---|
| EV / Earnings | n/a |
| EV / Sales | 1.02 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financialposition
| Measure | Value |
|---|
| Current Ratio | 12.06 |
| Quick Ratio | 6.89 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financialefficiency
| Measure | Value |
|---|
| Return on Equity (ROE) | -84.58% |
| Return on Assets (ROA) | -54.72% |
| Return on Invested Capital (ROIC) | -58.43% |
| Return on Capital Employed (ROCE) | -122.96% |
| Weighted Average Cost of Capital (WACC) | 19.32% |
| Revenue Per Employee | $262,463 |
| Profits Per Employee | -$591,275 |
| Employee Count | 13 |
| Asset Turnover | 0.35 |
| Inventory Turnover | 1.26 |
Taxes
| Measure | Value |
|---|
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stockprice
| Measure | Value |
|---|
| Beta (5Y) | 2.74 |
| 52-Week Price Change | -52.53% |
| 50-Day Moving Average | 0.89 |
| 200-Day Moving Average | 0.97 |
| Relative Strength Index (RSI) | 45.91 |
| Average Volume (20 Days) | 144,501 |
Shortselling
| Measure | Value |
|---|
| Short Interest | 145,869 |
| Short Previous Month | 180,001 |
| Short % of Shares Out | 1.67% |
| Short % of Float | 1.80% |
| Short Ratio (days to cover) | 0.83 |
Incomestatement
| Measure | Value |
|---|
| Revenue | 3.41M |
| Gross Profit | 777,543 |
| Operating Income | -8.50M |
| Pretax Income | -7.69M |
| Net Income | -7.69M |
| EBITDA | -8.38M |
| EBIT | -8.50M |
| Loss Per Share | -$1.34 |
Balancesheet
| Measure | Value |
|---|
| Cash & Cash Equivalents | 3.74M |
| Total Debt | n/a |
| Net Cash | 3.74M |
| Net Cash Per Share | $0.43 |
| Equity (Book Value) | 6.90M |
| Book Value Per Share | 1.08 |
| Working Capital | 6.22M |
Cashflow
| Measure | Value |
|---|
| Operating Cash Flow | -7.20M |
| Capital Expenditures | -31,865 |
| Depreciation & Amortization | 119,963 |
| Net Borrowing | -382,548 |
| Free Cash Flow | -7.23M |
| FCF Per Share | -$0.83 |
Margins
| Measure | Value |
|---|
| Gross Margin | 22.79% |
| Operating Margin | -249.03% |
| Pretax Margin | -225.28% |
| Profit Margin | -225.28% |
| EBITDA Margin | -245.51% |
| EBIT Margin | -249.03% |
| FCF Margin | n/a |
Dividends
| Measure | Value |
|---|
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -132.62% |
| Shareholder Yield | n/a |
| Earnings Yield | -161.30% |
| FCF Yield | -99.96% |
Analystforecasts
| Measure | Value |
|---|
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (3Y) | n/a |
| EPS Growth Forecast (3Y) | n/a |
Stocksplits
| Measure | Value |
|---|
| Last Split Date | Jul 18, 2024 |
| Split Type | Reverse |
| Split Ratio | 1:20 |
Scores
| Measure | Value |
|---|
| Altman Z-Score | -1.37 |
| Piotroski F-Score | 3 |
Fairvalue
| Measure | Value |
|---|
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |